Skip to main content
Erschienen in:

29.03.2024 | Original Article

Factors Impacting Outcome and Prognosis of Invasive Fungal Sinusitis: How Vital is Iron Metabolism?

verfasst von: Prankur Verma, Kapil Sikka, Hitesh Verma, Rakesh Kumar, Alok Thakar, Manish Soneja, Vishwajeet Singh

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Ausgabe 4/2024

Einloggen, um Zugang zu erhalten

Abstract

Iron is an important micronutrient involved in cell biology through vital reactions. We examined the correlations between iron metabolism parameters and the course of invasive fungal sinusitis. Patients with invasive fungal sinusitis were enrolled. Serum iron and ferritin levels, total iron-binding capacity, and transferrin saturation were measured at the initiation of treatment. Patients were followed for 6 months, and the clinical course was categorised as improvement or worsening/death. A total of 35 patients were enrolled. The average ferritin levels in mucormycosis patients was 944.9 ng/ml, versus 110.7 ng/ml for aspergillosis patients. Iron levels were significantly lower in mucormycosis than in aspergillosis (29.14 µg/dl vs. 68.55 µg/dl). Total iron-binding capacity was significantly different between the two groups (16.76 µg/dl vs. 330.36 µg/dl). After 6 months, improvement, worsening, and death were noted for 18, 8, and 9 patients, respectively. Higher iron levels and lower ferritin levels were linked with improvement. Total iron-binding capacity was significantly higher in improved patients (2314 vs. 151). Iron metabolism parameters play significant roles in the preemptive judgment of the course of fungal sinusitis. Based on these findings, studies on drugs affecting iron metabolism should be conducted.
Literatur
1.
Zurück zum Zitat Canessa P, Larrondo LF (2013) Environmental responses and the control of iron homeostasis in fungal systems. Appl Microbiol Biotechnol 97(3):939–955CrossRefPubMed Canessa P, Larrondo LF (2013) Environmental responses and the control of iron homeostasis in fungal systems. Appl Microbiol Biotechnol 97(3):939–955CrossRefPubMed
2.
Zurück zum Zitat Chakrabarti A, Chatterjee SS, Shivaprakash MR (2008) Overview of opportunistic fungal infections in India. Nihon Ishinkin Gakkai Zasshi Jpn J Med Mycol 49(3):165–172CrossRef Chakrabarti A, Chatterjee SS, Shivaprakash MR (2008) Overview of opportunistic fungal infections in India. Nihon Ishinkin Gakkai Zasshi Jpn J Med Mycol 49(3):165–172CrossRef
4.
Zurück zum Zitat Lugito NPH, Cucunawangsih C (2021) How does mucorales benefit from the dysregulated iron homeostasis during SARS-CoV-2 infection? Mycopathologia 186(6):877–882CrossRefPubMedPubMedCentral Lugito NPH, Cucunawangsih C (2021) How does mucorales benefit from the dysregulated iron homeostasis during SARS-CoV-2 infection? Mycopathologia 186(6):877–882CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Tabassum T, Araf Y, Moin AT, Rahaman TI, Hosen MJ (2022) COVID-19-associated-mucormycosis: possible role of free iron uptake and immunosuppression. Mol Biol Rep 49(1):747–754CrossRefPubMed Tabassum T, Araf Y, Moin AT, Rahaman TI, Hosen MJ (2022) COVID-19-associated-mucormycosis: possible role of free iron uptake and immunosuppression. Mol Biol Rep 49(1):747–754CrossRefPubMed
6.
Zurück zum Zitat Nyilasi I, Papp T, Takó M, Nagy E, Vágvölgyi C (2005) Iron gathering of opportunistic pathogenic fungi. A mini review. Acta Microbiol Immunol Hung 52(2):185–197CrossRefPubMed Nyilasi I, Papp T, Takó M, Nagy E, Vágvölgyi C (2005) Iron gathering of opportunistic pathogenic fungi. A mini review. Acta Microbiol Immunol Hung 52(2):185–197CrossRefPubMed
8.
Zurück zum Zitat Winkelmann G (1979) Surface iron polymers and hydroxy acids A model of iron supply in sideramine-free fungi. Arch Microbiol 121(1):43–51CrossRef Winkelmann G (1979) Surface iron polymers and hydroxy acids A model of iron supply in sideramine-free fungi. Arch Microbiol 121(1):43–51CrossRef
9.
Zurück zum Zitat Artis WM, Fountain JA, Delcher HK, Jones HE (1982) A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis transferrin and iron availability. Diabetes 31(12):1109–1114CrossRefPubMed Artis WM, Fountain JA, Delcher HK, Jones HE (1982) A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis transferrin and iron availability. Diabetes 31(12):1109–1114CrossRefPubMed
10.
11.
Zurück zum Zitat Iglesias-Osma C, Gonzalez-Villaron L, San Miguel JF, Caballero MD, Vazquez L, de Castro S (1995) Iron metabolism and fungal infections in patients with haematological malignancies. J Clin Pathol 48(3):223–225CrossRefPubMedPubMedCentral Iglesias-Osma C, Gonzalez-Villaron L, San Miguel JF, Caballero MD, Vazquez L, de Castro S (1995) Iron metabolism and fungal infections in patients with haematological malignancies. J Clin Pathol 48(3):223–225CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Kumar HM, Sharma P, Rudramurthy SM, Sehgal IS, Prasad KT, Pannu AK et al (2022) Serum iron indices in COVID-19-associated mucormycosis: a case-control study. Mycoses 65(1):120–127CrossRef Kumar HM, Sharma P, Rudramurthy SM, Sehgal IS, Prasad KT, Pannu AK et al (2022) Serum iron indices in COVID-19-associated mucormycosis: a case-control study. Mycoses 65(1):120–127CrossRef
14.
Zurück zum Zitat Khan I, M RB, S V (2022) Study on serum iron profile in COVID-19 associated mucormycosis patients. Int J Res Med Sci 10(5):1053–1058 Khan I, M RB, S V (2022) Study on serum iron profile in COVID-19 associated mucormycosis patients. Int J Res Med Sci 10(5):1053–1058
15.
Zurück zum Zitat Sazandeh FSS (2004) Serum ferritin in Type 2 diabetes mellitus and its relationship with HbA1c. Acta Med Iran 142–145 Sazandeh FSS (2004) Serum ferritin in Type 2 diabetes mellitus and its relationship with HbA1c. Acta Med Iran 142–145
16.
Zurück zum Zitat Kim NH, Oh JH, Choi KM, Kim YH, Baik SH, Choi DS et al (2000) Serum ferritin in healthy subjects and type 2 diabetic patients. Yonsei Med J 41(3):387–392CrossRefPubMed Kim NH, Oh JH, Choi KM, Kim YH, Baik SH, Choi DS et al (2000) Serum ferritin in healthy subjects and type 2 diabetic patients. Yonsei Med J 41(3):387–392CrossRefPubMed
17.
Zurück zum Zitat Canturk Z, Cetinarslan B, Tarkun I, Canturk NZ (2003) Serum ferritin levels in poorly- and well-controlled diabetes mellitus. Endocr Res 29(3):299–306CrossRefPubMed Canturk Z, Cetinarslan B, Tarkun I, Canturk NZ (2003) Serum ferritin levels in poorly- and well-controlled diabetes mellitus. Endocr Res 29(3):299–306CrossRefPubMed
18.
Zurück zum Zitat Ibrahim AS, Gebermariam T, Fu Y, Lin L, Husseiny MI, French SW et al (2007) The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J Clin Invest 117(9):2649–2657CrossRefPubMedPubMedCentral Ibrahim AS, Gebermariam T, Fu Y, Lin L, Husseiny MI, French SW et al (2007) The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J Clin Invest 117(9):2649–2657CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Vergne AF, Walz AJ, Miller MJ (2000) Iron chelators from mycobacteria (1954–1999) and potential therapeutic applications. Nat Prod Rep 17(1):99–116CrossRefPubMed Vergne AF, Walz AJ, Miller MJ (2000) Iron chelators from mycobacteria (1954–1999) and potential therapeutic applications. Nat Prod Rep 17(1):99–116CrossRefPubMed
20.
Zurück zum Zitat Bernier G, Girijavallabhan V, Murray A, Niyaz N, Ding P, Miller MJ et al (2005) Desketoneoenactin-siderophore conjugates for Candida: evidence of iron transport-dependent species selectivity. Antimicrob Agents Chemother 49(1):241–248CrossRefPubMedPubMedCentral Bernier G, Girijavallabhan V, Murray A, Niyaz N, Ding P, Miller MJ et al (2005) Desketoneoenactin-siderophore conjugates for Candida: evidence of iron transport-dependent species selectivity. Antimicrob Agents Chemother 49(1):241–248CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Lu Y, Miller MJ (1999) Syntheses and studies of multiwarhead siderophore-5-fluorouridine conjugates. Bioorg Med Chem 7(12):3025–3038CrossRefPubMed Lu Y, Miller MJ (1999) Syntheses and studies of multiwarhead siderophore-5-fluorouridine conjugates. Bioorg Med Chem 7(12):3025–3038CrossRefPubMed
22.
Zurück zum Zitat Ghosh M, Miller MJ (1995) Design, synthesis, and biological evaluation of isocyanurate-based antifungal and macrolide antibiotic conjugates: iron transport-mediated drug delivery. Bioorg Med Chem 3(11):1519–1525CrossRefPubMed Ghosh M, Miller MJ (1995) Design, synthesis, and biological evaluation of isocyanurate-based antifungal and macrolide antibiotic conjugates: iron transport-mediated drug delivery. Bioorg Med Chem 3(11):1519–1525CrossRefPubMed
Metadaten
Titel
Factors Impacting Outcome and Prognosis of Invasive Fungal Sinusitis: How Vital is Iron Metabolism?
verfasst von
Prankur Verma
Kapil Sikka
Hitesh Verma
Rakesh Kumar
Alok Thakar
Manish Soneja
Vishwajeet Singh
Publikationsdatum
29.03.2024
Verlag
Springer India
Erschienen in
Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe 4/2024
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-024-04643-6

Neu im Fachgebiet HNO

Die elektronische Patientenakte kommt: Das sollten Sie jetzt wissen

Am 15. Januar geht die „ePA für alle“ zunächst in den Modellregionen an den Start. Doch schon bald soll sie in allen Praxen zum Einsatz kommen. Was ist jetzt zu tun? Was müssen Sie wissen? Wir geben in einem FAQ Antworten auf 21 Fragen.

Kopf-Hals-Tumore: Lebensqualität von Langzeitüberlebenden

Eine aktuelle Studie des Universitätsklinikums Erlangen verdeutlicht, dass Langzeitüberlebende von Kopf-Hals-Tumoren eine geringe Symptomlast aufweisen. Die am häufigsten auftretenden Beschwerden – Müdigkeit, Angstzustände, Schläfrigkeit und Schmerzen – sollten von den behandelnden Ärztinnen und Ärzten gezielt adressiert werden.

Schlafapnoe – es lag an einer verbogenen Nasenscheidewand

Tritt eine obstruktive Schlafapnoe vor allem in einer bestimmten Seitenlage auf, kann dies auch an einem verbogenen Nasenseptum liegen. Eine Septumplastik lindert die Beschwerden mitunter deutlich.

Das alles ändert sich für Arztpraxen in 2025

  • 31.12.2024
  • EBM
  • Nachrichten

Ab Januar greifen jede Menge Neuerungen – ob im EBM, Arbeits- und Steuerrecht oder bei der digitalen Vernetzung. Darunter einige Verbesserungen, aber teils auch Mehraufwand. „Same procedure as every year?“ – Ein Überblick.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.